hrp0082p3-d3-843 | Growth (2) | ESPE2014

Two Years of GH Therapy in Children with Growth Deficiency

Bessahraoui Mimouna , Niar Sakina , Naceur Malika , Bouziane-Nedjadi Karim

Background: GH therapy improves height outcome in children with GH deficiency (GHD). Height velocity (HV) is maximum in the first year of treatment. Early diagnosis and therapy initiation optimize growth outcomes.Objective and hypotheses: Of this study was to evaluate growth during the first 2 years of GH treatment in 33 GHD children and evaluated the height velocity.Method: The study enrolled 54 children (29 boys, and 25 girls) wi...

hrp0082p3-d3-872 | Growth (4) | ESPE2014

Descriptive Analyses of Turner Syndrome

Bessahraoui Mimouna , Naceur Malika , Niar Sakina , Zennaki Amel , Arbi Farouk , Ousaleh Meriem , Bouziane-Nedjadi Karim

Background: Turner syndrome (TS) is a genetic syndrome caused by complete or partial absence of an X chromosome. It is the most common diagnosed sex chromosome abnormality in women, affecting 1/2000–2500 female live births.Objective and hypotheses: To determine to establish the clinical, hormonal, cytogenetic, and evolutive pattern of children with TS and to establish for correlations between genotype and phenotype.Method: We ...